BR9510444A - Soluções de injeção ou de infusão de enrofloxacin - Google Patents

Soluções de injeção ou de infusão de enrofloxacin

Info

Publication number
BR9510444A
BR9510444A BR9510444A BR9510444A BR9510444A BR 9510444 A BR9510444 A BR 9510444A BR 9510444 A BR9510444 A BR 9510444A BR 9510444 A BR9510444 A BR 9510444A BR 9510444 A BR9510444 A BR 9510444A
Authority
BR
Brazil
Prior art keywords
enrofloxacin
injection
infusion solutions
infusion
solutions
Prior art date
Application number
BR9510444A
Other languages
English (en)
Inventor
Martin Hamm Michael Stegemann
Hanns Peter Mueller
Gerhard Bonse
Arundev Haribhai Naik
Oliver Vetter
Martin Scheer
Martin Hamm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9510444A publication Critical patent/BR9510444A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9510444A 1995-01-13 1995-12-28 Soluções de injeção ou de infusão de enrofloxacin BR9510444A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19500784A DE19500784A1 (de) 1995-01-13 1995-01-13 Enrofloxacin-Injektions- oder Infusionslösungen
PCT/EP1995/005147 WO1996021453A1 (de) 1995-01-13 1995-12-28 Enrofloxacin-injektions- oder infusionslösungen

Publications (1)

Publication Number Publication Date
BR9510444A true BR9510444A (pt) 1998-05-19

Family

ID=7751383

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510444A BR9510444A (pt) 1995-01-13 1995-12-28 Soluções de injeção ou de infusão de enrofloxacin

Country Status (28)

Country Link
US (1) US5998418A (pt)
EP (1) EP0806955B1 (pt)
JP (1) JP3835815B2 (pt)
CN (1) CN1125635C (pt)
AR (1) AR002265A1 (pt)
AT (1) ATE261731T1 (pt)
AU (1) AU695171B2 (pt)
BR (1) BR9510444A (pt)
CA (1) CA2210076C (pt)
CZ (1) CZ293934B6 (pt)
DE (2) DE19500784A1 (pt)
DK (1) DK0806955T3 (pt)
ES (1) ES2215183T3 (pt)
FI (1) FI119970B (pt)
HU (1) HU226826B1 (pt)
IL (1) IL116726A (pt)
JO (1) JO1883B1 (pt)
MX (1) MX9705266A (pt)
NO (1) NO313537B1 (pt)
NZ (1) NZ298778A (pt)
PL (1) PL182095B1 (pt)
PT (1) PT806955E (pt)
RU (1) RU2147225C1 (pt)
SK (1) SK284348B6 (pt)
TW (1) TW416852B (pt)
UA (1) UA42819C2 (pt)
WO (1) WO1996021453A1 (pt)
ZA (1) ZA96244B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE102004054873A1 (de) * 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
BRPI0518853A2 (pt) * 2004-12-09 2008-12-09 Bayer Healthcare Ag estabilizaÇço de Ésteres de glicocorticàides com Ácidos
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CN100341510C (zh) * 2005-06-10 2007-10-10 冯莉萍 一种恩诺沙星微囊及制备方法
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
CN101230333B (zh) * 2007-01-26 2010-08-18 台湾尖端先进生技医药股份有限公司 恩罗氟沙星的单株抗体及其检测套组
US20100247687A1 (en) * 2009-03-30 2010-09-30 Mary Arnold-Ronish Formulation for tattoo removal and method of using same
CN101810569B (zh) * 2010-05-22 2011-09-21 鼎正动物药业（天津）有限公司 一种恩诺沙星注射液及其制备方法
CN103479569A (zh) * 2013-01-14 2014-01-01 四川喜亚动物药业有限公司 兽用环丙沙星注射液及其制备方法
RU2574007C2 (ru) * 2013-10-16 2016-01-27 Олег Иванович Киселев Инъекционный раствор для лечения вирусных заболеваний, выбранных из гриппа h1n1, h3n2, h5n1, клещевого энцефалита и лихорадки западного нила
US9993421B2 (en) * 2015-11-20 2018-06-12 Dynamo, Llc Method for treating deleterious effects arising from tattoos
CN107095848A (zh) * 2017-07-01 2017-08-29 山东中牧兽药有限公司 一种恩诺沙星注射液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
HU188181B (en) * 1981-06-11 1986-03-28 Warner-Lambert Co,Us Process for producing salts of naphtiridine and quinoline compounds of antimicrobial activity
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
IL116726A0 (en) 1996-05-14
JP3835815B2 (ja) 2006-10-18
PT806955E (pt) 2004-06-30
FI119970B (fi) 2009-05-29
CA2210076A1 (en) 1996-07-18
NO973223D0 (no) 1997-07-10
CZ213097A3 (en) 1997-10-15
PL321259A1 (en) 1997-11-24
NO313537B1 (no) 2002-10-21
SK284348B6 (sk) 2005-02-04
ZA96244B (en) 1996-07-31
MX9705266A (es) 1997-10-31
AU695171B2 (en) 1998-08-06
EP0806955B1 (de) 2004-03-17
AU4434996A (en) 1996-07-31
HU226826B1 (en) 2009-11-30
NZ298778A (en) 1999-05-28
SK94697A3 (en) 1997-11-05
RU2147225C1 (ru) 2000-04-10
FI972966A0 (fi) 1997-07-11
PL182095B1 (pl) 2001-11-30
DE19500784A1 (de) 1996-07-18
CN1177300A (zh) 1998-03-25
NO973223L (no) 1997-07-10
IL116726A (en) 2000-07-16
JO1883B1 (en) 1996-07-25
WO1996021453A1 (de) 1996-07-18
US5998418A (en) 1999-12-07
ATE261731T1 (de) 2004-04-15
EP0806955A1 (de) 1997-11-19
JPH10511967A (ja) 1998-11-17
TW416852B (en) 2001-01-01
HUT77942A (hu) 1998-12-28
FI972966A (fi) 1997-07-11
DK0806955T3 (da) 2004-07-12
ES2215183T3 (es) 2004-10-01
CZ293934B6 (cs) 2004-08-18
DE59510878D1 (de) 2004-04-22
CA2210076C (en) 2007-12-18
CN1125635C (zh) 2003-10-29
UA42819C2 (uk) 2001-11-15
AR002265A1 (es) 1998-03-11

Similar Documents

Publication Publication Date Title
DE69627070T2 (de) Flüssigkeitseinspritzdüse
IS4646A (is) Stungunál fyrir gegnflæðiskerfi
BR9510444A (pt) Soluções de injeção ou de infusão de enrofloxacin
PT963211E (pt) Sistema de injeccao hipodermica
DE69605402T2 (de) Infusionssystem
BR9612621A (pt) Sistema de injeção de aditivo de caixo superior
BR9304747A (pt) Injetor de medicamentos
FI970132A (fi) Injektioruisku
DE69605168D1 (de) Einspritzventil
DE69625992D1 (de) Einspritzventil
DE59602366D1 (de) Einspritzdüse
DE59606137D1 (de) Einspritzeinrichtung
KR970003871U (ko) 분사관의 연결구
KR970024140U (ko) 인젝터의 분사홀
KR950025625U (ko) 액정표시소자의 액정주입구
KR960034527U (ko) 액체류 주입기
KR960036443U (ko) 액체 분사장치
SE9502763D0 (sv) Injektionssystem
KR970020893U (ko) 주사용 바늘
KR970005776U (ko) 약품주입 펌프의 투입량 지시장치
KR960027506U (ko) 원심 분사식 연소가스 처리장치
UA134U (uk) Голка для ін'єкцій
BR9502898A (pt) Aparelho destruidor de agulhas hipodermicas
UA25842C2 (uk) Протиалкогольhий засіб для іh'єкцій
KR970024138U (ko) 인젝터

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: EN ATENDIMENTO A SOLICITACAO FORMULADA CABE-NOS ESCLARECER QUE DEVIDAS PROVIDENCIAS JA FORAM TOMADAS E, EM CONSEQUENCIA, O TITULO FOI RETIFICADO.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/03/2006, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 01/03/2016